Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.

Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res (2009) 1.42

Thymic malignancies: from clinical management to targeted therapies. J Clin Oncol (2011) 1.25

Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas. Cancer (2010) 1.04

Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study. J Thorac Oncol (2010) 0.88

KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE). Diagn Pathol (2014) 0.78

Tumor-related gene expression levels in thymic carcinoma and Type B3 thymoma. J Cardiothorac Surg (2016) 0.75

Rare frequency of gene variation and survival analysis in thymic epithelial tumors. Onco Targets Ther (2016) 0.75

Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma. J Thorac Dis (2016) 0.75

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (2004) 61.56

The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88

Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48

High-throughput oncogene mutation profiling in human cancer. Nat Genet (2007) 12.68

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med (2006) 6.96

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med (2012) 6.77

Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res (2004) 3.37

miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res (2008) 2.80

Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks. Cell (2003) 2.38

RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res (2006) 2.21

Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors. Proc Natl Acad Sci U S A (2006) 2.17

PIK3CA mutation status in Japanese lung cancer patients. Lung Cancer (2006) 2.15

Genotyping analyses for polymorphisms of ANXA5 gene in patients with recurrent pregnancy loss. Fertil Steril (2013) 2.02

microRNA expression profile in undifferentiated gastric cancer. Int J Oncol (2009) 1.95

Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung. Lung Cancer (2006) 1.78

Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Oncol Rep (2007) 1.62

Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol (2011) 1.53

EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Clin Cancer Res (2005) 1.47

Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer. Breast Cancer (2006) 1.42

Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep (2007) 1.42

Characteristics of lung cancers harboring NRAS mutations. Clin Cancer Res (2013) 1.41

Successful delivery derived from vitrified-warmed spermatozoa from a patient with nonobstructive azoospermia. Fertil Steril (2012) 1.41

EGFR and erbB2 mutation status in Japanese lung cancer patients. Int J Cancer (2006) 1.40

Preservation of phrenic nerve involved by stage III thymoma. Ann Thorac Surg (2010) 1.38

Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2011) 1.35

EGFR exon 20 insertion mutation in Japanese lung cancer. Lung Cancer (2007) 1.32

Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer. Cancer Sci (2008) 1.31

PIK3CA gene amplification in Japanese non-small cell lung cancer. Lung Cancer (2007) 1.30

Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol (2009) 1.30

Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol (2002) 1.29

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene (2002) 1.29

Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer (2005) 1.28

Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer. Endocr Relat Cancer (2008) 1.25

Thoracic and cardiovascular surgery in Japan during 2008: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2010) 1.24

Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol (2008) 1.22

Carbon nanotube growth from diamond. J Am Chem Soc (2009) 1.21

Factors associated with outcome of segmentectomy for non-small cell lung cancer: long-term follow-up study at a single institution in Japan. Lung Cancer (2007) 1.19

Thoracic and cardiovascular surgery in Japan during 2006: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2008) 1.18

Cten mRNA expression was correlated with tumor progression in lung cancers. Lung Cancer (2003) 1.18

Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis (2002) 1.18

Uncommon V599E BRAF mutations in Japanese patients with lung cancer. J Surg Res (2005) 1.16

Histone deacetylase 1 mRNA expression in lung cancer. Lung Cancer (2004) 1.14

Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol (2010) 1.13

Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. Oncogene (2003) 1.13

HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Res (2005) 1.13

Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer. Breast Cancer Res (2005) 1.12

Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma. J Thorac Oncol (2006) 1.09

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers. BMC Cancer (2008) 1.09